Report received of discrepant inratio values.Patient's therapeutic range 2-3.On (b)(6) 2016 inratio inr = 2.2.On (b)(6) 2016 lab inr = 16.On (b)(6) 2016 patient was admitted to (b)(6) medical center for bleeding from a pre-existing diabetic wound that was being treated; laboratory inr conducted upon admittance, lab inr=16.Following laboratory inr, coumadin was held for 3 days.Patient was also administered vitamin k and fluids for three days.Patient was not given any other medications/treatments.On (b)(6) 2016 patient was discharged from hospital with a lab inr = 6.5.Caller provided diagnosis as bleeding and critical inr.On (b)(6) 2016 inratio inr = 2.4.On (b)(6) 2016 inratio inr = 4.2 and lab inr = 4.9 (testing occurred simultaneously).Coumadin dose prior to (b)(6): 5 mg x3/week, 2.5 mg x4/week.Coumadin dose after (b)(6): 2.5 mg/day.
|